Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Recurrence 2Leukemia, Lymphocytic, Chronic, B-Cell 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1

Interventions

venetoclax 28Rituximab 22ibrutinib 21acalabrutinib 21Cyclophosphamide 20Specimen Handling 18obinutuzumab 15Biopsy 14fludarabine 13zanubrutinib 10pirtobrutinib 10fludarabine phosphate 9Magnetic Resonance Spectroscopy 8Bendamustine Hydrochloride 8idelalisib 6Whole-Body Irradiation 6Mycophenolic Acid 6Lenalidomide 6CT-P10 6ARQ531 6Cyclosporine 5Sirolimus 4Peripheral Blood Stem Cell Transplantation 4pembrolizumab 3Vincristine 3Tacrolimus 3Prednisone 3Doxorubicin 3Disulfides 3Cyclosporins 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Lymphocytic, Chronic, B-Cell × Lisaftoclax × 90 days × Clear all
NCT03913949 2026-05-01

A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

Ascentage Pharma Group Inc.

Phase 1 Active not recruiting
74 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05147467 2026-03-27

Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL

Ascentage Pharma Group Inc.

Phase 2 Recruiting
75 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡